Pierre Falardeau
Chairman at Folia Biotech, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michel Fortin | M | - |
EVAH Corp.
 EVAH Corp. Information Technology ServicesTechnology Services EVAH Corp. develops animal health technologies. The Canadian company was founded in 2020 by Michel Fortin and Nicole Blanchard. Michel Fortin has been the CEO since 2020. | - |
| Nicole Blanchard | F | - |
EVAH Corp.
EVAH Corp. Information Technology ServicesTechnology Services EVAH Corp. develops animal health technologies. The Canadian company was founded in 2020 by Michel Fortin and Nicole Blanchard. Michel Fortin has been the CEO since 2020. | - |
| Jacques Bernier | M | - |
Folia Biotech, Inc.
 Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada.
Université Laval
| 5 years |
| Denis Leclerc | M | - |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | 18 years |
| Louis R. Lamontagne | M | - |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | 10 years |
| Me Charles Denault | M | - |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | - |
| Brian Levitt | M | 76 |
EVAH Corp.
EVAH Corp. Information Technology ServicesTechnology Services EVAH Corp. develops animal health technologies. The Canadian company was founded in 2020 by Michel Fortin and Nicole Blanchard. Michel Fortin has been the CEO since 2020. | - |
| Martin Roberge | M | - |
EVAH Corp.
EVAH Corp. Information Technology ServicesTechnology Services EVAH Corp. develops animal health technologies. The Canadian company was founded in 2020 by Michel Fortin and Nicole Blanchard. Michel Fortin has been the CEO since 2020. | - |
| Peter Morand | M | 88 |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | - |
| André Boulet | M | - |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | - |
| Martin LeBlanc | M | 58 |
EVAH Corp.
EVAH Corp. Information Technology ServicesTechnology Services EVAH Corp. develops animal health technologies. The Canadian company was founded in 2020 by Michel Fortin and Nicole Blanchard. Michel Fortin has been the CEO since 2020. | - |
| Patrice Allibert | M | - |
Folia Biotech, Inc.
Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | - |
| Matthias Gerlach | M | - | 23 years | |
| Frederic Beaulac | M | - |
EVAH Corp.
EVAH Corp. Information Technology ServicesTechnology Services EVAH Corp. develops animal health technologies. The Canadian company was founded in 2020 by Michel Fortin and Nicole Blanchard. Michel Fortin has been the CEO since 2020. | - |
| Martin Moreno Izquierdo | M | - |
EVAH Corp.
EVAH Corp. Information Technology ServicesTechnology Services EVAH Corp. develops animal health technologies. The Canadian company was founded in 2020 by Michel Fortin and Nicole Blanchard. Michel Fortin has been the CEO since 2020. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gary Littlejohn | M | 68 |
Ecopia BioSciences, Inc.
 Ecopia BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Ecopia is finding novel anticancer therapies from soil-dwelling micro organisms that are as of this day one of the most prolific sources of these drugs. Their current focus is ECO-4601, a new small molecule that crosses the blood brain barrier and is effective in significantly inhibiting primary tumor growth in the brain. Just like well-known chemotherapies such as doxorubicin and daunorubicin, ECO-4601 comes from microorganisms that live in common soil. ECO-4601 represents a new chemical class that is the fruit of a very unique drug discovery platform called the Decipher® technology | 6 years |
| Michael Singer | M | 60 | 7 years | |
| Franklin Berger | M | 74 | 6 years | |
| Claude Belleville | M | - |
Université Laval
| 6 years |
| Gaétan Duplain | M | - |
Université Laval
| 5 years |
| Mario Paradis | M | - | - | |
| Noël Dubé | M | 63 |
Université Laval
| 6 years |
| Roberto Bellini | M | 44 | 6 years | |
| Claude C. Bismuth | M | - | - | |
| Jacques Turgeon | M | - |
Université Laval
| 4 years |
| Louis Theriault | M | - |
Université Laval
| 5 years |
| François Chabot | M | - |
Université Laval
| 6 years |
| Claude Pouliot | M | - |
Université Laval
| 5 years |
| Fabien Miller | M | - |
Université Laval
| 6 years |
| Gilles Gagnon | M | 70 | 8 years | |
| Sylvie Grégoire | M | 62 |
Université Laval
| 4 years |
| Dany pelletier | M | - |
Université Laval
| 6 years |
| Claude Bouchard | M | - |
Université Laval
| 4 years |
| Richard Painchaud | M | 60 |
Université Laval
| 4 years |
| Jean Laforest | M | - |
Université Laval
| 4 years |
| Daniel Goulet | M | - |
Université Laval
| 4 years |
| Jocelyn Lafond | M | 56 |
Université Laval
| 3 years |
| Susan Kudzman | F | 61 |
Université Laval
| 4 years |
| Éric Pineau | M | - |
Université Laval
| 4 years |
| Alain Tremblay | M | - |
Université Laval
| 4 years |
| Osman Reha Yolalan | M | 63 |
Université Laval
| 3 years |
| François Paquet | M | - |
Université Laval
| 4 years |
| Alain Vallieres | M | - |
Université Laval
| 4 years |
| Pierre Massicotte | M | 58 |
Université Laval
| 4 years |
| Donald Trudel | M | - |
Université Laval
| 4 years |
| Richard Grondin | M | - |
Université Laval
| 4 years |
| André La Forge | M | - |
Université Laval
| 5 years |
| André Bilodeau | M | - |
Université Laval
| 4 years |
| Denis Boucher | M | 58 |
Université Laval
| 3 years |
| Maude Lemieux | F | - |
Université Laval
| 4 years |
| Martin Morand | M | - |
Université Laval
| 4 years |
| Jacques Beauvais | M | - |
Université Laval
| 3 years |
| Olivier Chouc | M | - |
Université Laval
| 3 years |
| Pierre Soulard | M | 56 |
Université Laval
| 4 years |
| Jean Raby | M | 60 |
Université Laval
| 3 years |
| Pierre Olivier | M | - |
Université Laval
| 4 years |
| Claude Pelletier | M | - |
Université Laval
| 4 years |
| Richard Blanchet | M | - |
Université Laval
| 4 years |
| Alain Doucet | M | - |
Université Laval
| 4 years |
| Stéphane Blanchette | M | - |
Université Laval
| 4 years |
| Jacques Topping | M | - |
Université Laval
| 2 years |
| Patrice Nadeau | M | - |
Université Laval
| 4 years |
| Isabelle Proulx | F | - |
Université Laval
| 4 years |
| Michel Gervais | M | 78 |
Université Laval
| 10 years |
| Halvor Jaeger | M | - | 1 years | |
| Pierre Simard | M | 59 |
Université Laval
| - |
| Guy Girard | M | 62 |
Université Laval
| 4 years |
| Jacques Simoneau | M | 66 |
Université Laval
| 1 years |
| Louis Têtu | M | 59 |
Université Laval
| 4 years |
| Jacques Marcotte | M | - |
Université Laval
| 3 years |
| Stéphane Corriveau | M | - |
Université Laval
| 4 years |
| Jean-Luc Meunier | M | 60 |
Université Laval
| 4 years |
| Stéphane Robert | M | - |
Université Laval
| 4 years |
| Michel Rhéaume | M | - |
Université Laval
| 3 years |
| Vital Proulx | M | - |
Université Laval
| 4 years |
| Ian Scullion | M | - |
Université Laval
| 4 years |
| Pierre Laurin | M | 63 | 12 years | |
| Pierre MacDonald | M | - | 10 years | |
| Daniel Buron | M | 60 |
Université Laval
| 4 years |
| Alain-Jacques Simard | M | - |
Université Laval
| 4 years |
| Marc Gagnon | M | - |
Université Laval
| 5 years |
| Gino Roger | M | - |
Université Laval
| 4 years |
| Stéphane Vidal | M | - |
Université Laval
| 4 years |
| Edouard Merette | M | 62 |
Université Laval
| 4 years |
| Martial Gagné | M | - |
Université Laval
| 4 years |
| Alexander Dann | M | 57 |
Université Laval
| 4 years |
| Stormy Byorum | F | 75 | 9 years | |
| Patrick Godin | M | 54 |
Université Laval
| 4 years |
| Mario Lemay | M | - |
Université Laval
| 2 years |
| Richard Bordeleau | M | - | 6 years | |
| Daniel Racine | M | 61 |
Université Laval
| 4 years |
| Jean Martineau | M | - |
Université Laval
| 4 years |
| Jamie Lewin | M | 74 |
Université Laval
| 3 years |
| Francois Giguere | M | - |
Université Laval
| 4 years |
| Lucien Pomerleau | M | - |
Université Laval
| 1 years |
| Marc Villeneuve | M | - |
Université Laval
| 3 years |
| M. Guy Bédard | M | - |
Université Laval
| 4 years |
| Daniel Bordeleau | M | - |
Université Laval
| 4 years |
| Ghislain Lafrance | M | - |
Université Laval
| 4 years |
| Jacques Desrochers | M | - |
Université Laval
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Pierre Falardeau
- Personal Network
